245 results on '"Doranz, Benjamin J."'
Search Results
2. Isolation of human antibodies against influenza B neuraminidase and mechanisms of protection at the airway interface
3. Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity
4. Zika-specific neutralizing antibodies targeting inter-dimer envelope epitopes
5. Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypes
6. Antibody specificity against highly conserved membrane protein Claudin 6 driven by single atomic contact point
7. Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations
8. Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein
9. A VHH single-domain platform enabling discovery and development of monospecific antibodies and modular neutralizing bispecifics against SARS-CoV-2 variants.
10. Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics
11. Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope
12. An affinity-matured human monoclonal antibody targeting fusion loop epitope of dengue virus with in vivo therapeutic potency
13. Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape
14. Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor
15. An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer
16. Isolation of state-dependent monoclonal antibodies against the 12-transmembrane domain glucose transporter 4 using virus-like particles
17. Structural basis for nonneutralizing antibody competition at antigenic site II of the respiratory syncytial virus fusion protein
18. Single B cell transcriptomics identifies multiple isotypes of broadly neutralizing antibodies against flaviviruses.
19. Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2–MPER region
20. Mxra8 is a receptor for multiple arthritogenic alphaviruses
21. Differential Utilization of CCR5 by Macrophage and T Cell Tropic Simian Immunodeficiency Virus Strains
22. Signal transmission through the CXC chemokine receptor 4 (CXCR4) transmembrane helices
23. Cryo-EM structures elucidate neutralizing mechanisms of anti-chikungunya human monoclonal antibodies with therapeutic activity
24. A Small-molecule Inhibitor Directed against the Chemokine Receptor CXCR4 Prevents its Use as an HIV-1 Coreceptor
25. Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice
26. HCV E2 core structures and mAbs: something is still missing
27. RETRACTED: Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity
28. Atomic-level functional model of dengue virus Envelope protein infectivity
29. Targeting of HIV- and SIV-Infected Cells by CD4-Chemokine Receptor Pseudotypes
30. Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8⁺ T cells
31. Breaking barriers in antibody discovery: harnessing divergent species for accessing difficult and conserved drug targets.
32. Cell-Free Assay of G-Protein-Coupled Receptors Using Fluorescence Polarization
33. A high-throughput shotgun mutagenesis approach to mapping B-cell antibody epitopes
34. Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage libraries.
35. Chemokine receptors as fusion cofactors for human immunodeficiency virus type 1 (HIV-1)
36. CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neuroviolent simian immunodeficiency virus strain
37. Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity
38. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
39. A dual-tropic primary HIV-1 isolate that uses Fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
40. Proteo-Genomic Analysis Identifies Two Major Sites of Vulnerability on Ebolavirus Glycoprotein for Neutralizing Antibodies in Convalescent Human Plasma.
41. Antigenicity, stability, and reproducibility of Zika reporter virus particles for long-term applications.
42. CCR5 Binds Multiple CC-Chemokines: MCP-3 Acts as a Natural Antagonist
43. Atomic-level mapping of antibody epitopes on a GPCR
44. Virus-like particles as quantitative probes of membrane protein interactions
45. Potent neutralizing antibodies elicited by dengue vaccine in rhesus macaque target diverse epitopes.
46. Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcγR interaction on monocytes.
47. Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope.
48. Increased breadth of HIV-1 neutralization achieved by diverse antibody clones each with limited neutralization breadth.
49. Human antibody recognition of antigenic site IV on Pneumovirus fusion proteins.
50. Enhancing antibody patent protection using epitope mapping information.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.